Skip to main content
. Author manuscript; available in PMC: 2016 Aug 18.
Published in final edited form as: J Biomed Inform. 2015 Sep 12;58(Suppl):S171–S182. doi: 10.1016/j.jbi.2015.09.006

Table 2.

Three types of clinical evidence regarding various risk factors

Evidence Type Risk Factor Indicator Example
Token-level
Clinical Entity
CAD:mention ‘CAD’, ‘3-vessel coronary artery disease’, ‘Coronary arteriosclerosis’
DIABETES:mention ‘DM’, ‘DMII’, ‘Diabetes mellitus’, ‘non-insulin-dependent diabetes’
OBESE:mention ‘moderately obese’, ‘mild obesity’, ‘obesity-related conditions’
HYPERLIMIDEMIA:mention ‘elevated cholesterol’, ‘hypercholesterolemia’, ‘hyperlipidemia’
HYPERTENSION:mention ‘HTN’, ‘hypertension’, ‘hypertensive’
MEDICATION (+18) ‘lisinopril’, ‘Zestril (LISINOPRIL)’, ‘Insulin 70/30 HUMAN 70-30’
Sentence-level
Clinical Fact
CAD:event ‘stenting at that time, and subsequently had another stent placed in 2076’
CAD:test ‘The pre-intervention stenosis was 95% with 0% residual stenosis’
CAD:symptom ‘has been getting chest pain and pressure with some shortness of breath’
SMOKER:current ‘Smokes about a half pack per day’, ‘Tob: 2 pack/y since 30 yo’
SMOKER:ever ‘50 pack year cigarette smoking history’, ‘History of tobacco use’
SMOKER:never ‘Tob: denies’, ‘Nonsmoker’, ‘no history of smoking’, ‘does not drink, smoke’
SMOKER:past ‘Tobacco: 1ppd from 14–50, quit 26 years ago’, ‘Remote h/o smoking’
FAMILY:present ‘Mother died in her 50s of CAD’, ‘Brother – CABG with redo in his 40’s’
Sentence-level
Clinical Measurement
DIABETES:AlC ‘Last A1c was 13.9. 5/23’, ‘HbA1c 01/13/2121 7.50
DIABETES:glucose ‘FS: 109160, ‘blood sugars were found to be in the 300400s
OBESE:BMI ‘BMI 31.9’, ‘BMI = 35 -> 32/33’, ‘BMI = 35
HYPERLIMIDEMIA:high LDL ‘Cholesterol-LDL 11/25/2115 121’, ‘LDL 196’, ‘Her last LDL was over 100
HYPERLIMIDEMIA:high chol. ‘cholesterol level was total 283’, ‘Cholesterol 242’, ‘cholesterol of 319
HYPERTENSION:high bp ‘BP: 190/102’, ‘blood pressure of 140/82’, ‘SBP 140–160mmHg’